InvestorsHub Logo
icon url

PPHMownsME

12/18/10 11:49 AM

#59204 RE: jessme #59201

Jess,

Even a blind squirrel finds a nut once in a while.
icon url

cheynew

12/18/10 11:56 AM

#59205 RE: jessme #59201

Sounds pretty accurate.
icon url

Frustrated

12/18/10 12:19 PM

#59209 RE: jessme #59201

Peregrine Pharmaceuticals has strong business growth and is run by inefficient management.

Don't these people know that only the science matters. Mgmt has nothing to do with it according to our supporters. The question is if mgmt doesn't matter why do we have to keep giving them ridiculous incentive options when they haven't even performed to their own milestones? All imo.
icon url

djohn

12/19/10 12:23 PM

#59224 RE: jessme #59201

Here you go jessme to compare PPHM to DNDN reports by SADIF.


2010-09-03
SADIF Analytics rates Dendreon Corporation as a low quality company with a neutral outlook

Ilhavo, Portugal – SADIF Investment Analytics, announces a new summary due diligence report covering Dendreon Corporation (DNDN). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Dendreon Corporation investor.

Report Summary: Dendreon Corporation is a low quality company with a neutral outlook. Dendreon Corporation has weak business growth and is run by mediocre management.

Company should be called SAD IF they knew what they were doing.

http://www.pr-inside.com/sadif-analytics-rates-dendreon-corporation-as-r2093959.htm